Back

Long-term patient clinical benefits and healthcare utilization after pulsed field ablation in paroxysmal atrial fibrillation: sub-analyses from the multicenter inspIRE trial

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Pulsed field ablation for atrial fibrillation ablation: latest findings Rhythm Control, Catheter Ablation ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Tom De Potter

Cardiovascular Research Center Aalst, Aalst (Belgium)

5 More presentations in this session

Presentation thumbnail
Incidence of acute pericarditis after pulsed-field ablation for the treatment of atrial fibrillation
Ms C. Isenegger (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Characterization of sedation strategies in real-world use of pulsed field ablation: sub-analysis of the EU-PORIA registry
Professor K. Chun (Frankfurt, DE)
Abstract Slides
Presentation thumbnail
Pulsed-field ablation for atrial fibrillation with a novel simplified protocol: the Swiss PFA dose multicenter study
Associate Professor P. Badertscher (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Risk and management of acute kidney injury resulting from hemoglobinuria following pulsed-field ablation in atrial fibrillation
Doctor S. Mohanty (Austin, US)
Abstract Slides Video
Presentation thumbnail
Influence of a three-dimensional mapping system on acute safety and efficacy of pulsed-field ablation for atrial fibrillation
Doctor R. Rordorf (Pavia, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Pulsed field ablation for atrial fibrillation ablation: latest findings
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources